
|Articles|September 17, 2021
AJMC® in the Press, September 17, 2021
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
A daily news roundup by
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
2
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
3
Defunding Co-Payment Assistance Disrupted nAMD Care
4
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
5




